The largest database of trusted experimental protocols

8 protocols using cd144 pe

1

Flow Cytometric Characterization of Adherent and Suspension Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adherent cells were washed with Dulbecco's PBS (DPBS) (Thermo Fisher, Waltham, MA, #12563011) and treated with Tryp‐LE Select (Thermo Fisher, Waltham, MA, #12563011) at 37°C for 5 minutes, followed by gentle pipetting to complete cell dissociation. The dissociated cells were then washed with DPBS several times before antibody staining for flow cytometry. For suspension hematopoietic cells, gentle pipetting was used to dislodge any loosely adhered hematopoietic cells from the adherent stromal layer, and the cells were washed multiple times with PBS before staining. Cells were stained in ice‐cold fluorescence‐activated cell sorting buffer (PBS, 1% BSA). Antibodies used; KDR‐PE (BD Pharmingen, San Jose, CA, #560872), CD34‐APC (BD, San Jose, CA, #555824), CD144‐PE (BD, San Jose, CA, #561714), CD45‐PE (BD, San Jose, CA, #561866), CD117‐APC (Thermo Fisher, Waltham, MA, clone 104D2), CD117‐PE (BD, San Jose, CA, #555714), CD235a‐FITC/PE (BD, San Jose, CA, Clone GA‐R2 (HIR2)), CD41a‐APC (BD, San Jose, CA, #559777), CD71‐FITC (BD, San Jose, CA, #555536), CD73‐PE (BD, San Jose, CA, #561014), CXCR4‐Biotin (BD, San Jose, CA, #555973), and Streptavidin‐FITC (BD, San Jose, CA, #554060). Flow cytometry was conducted on a Stratadigm S1000EXI or Beckton Dickinson (BD) dual‐laser FacsCalibur flow cytometer. Analyses were conducted using FlowJo v8.7 (FlowJo, LLC) software.
+ Open protocol
+ Expand
2

Vascular Immune Organoid Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vascular immune organoids (VIOs) were washed with PBS three times and were dissociated by 30 min incubation of accumax (StemCell Technologies, 07921). Cells were washed once and resuspended in 100 μl blocking buffer (2%FBS and 1% FcX (BioLegend, 422302) in PBS) at room temperature for 10 min. Optimal concentration of CD144-PE (BD, 561714) and CD31-PE-Cy7 (BD, 563651) were added into the blocking buffer and were incubated for 30 min on ice. Cells were washed with PBS once, followed by a centrifugation at 500g for 5 min to remove supernatant.Cells were resuspended in sufficient staining buffer (2% FBS in PBS) with DAPI. Analysis were performed on a BD FACSymphony A3 cell analyzer. Single cells were gated based on FSC-A vs FSC-H, followed by the removal of dead cells by removing DAPI+ cells.
+ Open protocol
+ Expand
3

Multicolor Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
For FCM analysis, all FACS antibodies were directly labeled and obtained from BD Pharmingen (CD34-PE, CD38-FITC, CD144-PE, CD31-FITC, IgG1-PE, and IgG1-FITC). All antibodies (5 μl) were incubated in 50-μl-reaction volume at 37 °C for 30 min before detection. An isotype-matched antibody was served as a negative control. Cell analysis and sorting were performed on Accuri C6 (BD Biosciences). Data were analyzed using BD Accuri C6 software.
+ Open protocol
+ Expand
4

Comprehensive Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following Abs were used for flow cytometry: CD115 Alexa Fluor 488 (AFS98, BioLegend, 135512), CD93 PerCP-Cy5.5 (AA4.1, BioLegend, 136512), CD144 PE (11D4.1, BD Biosciences, 562243), F4/80 PE-CF594 (T45-2342, BD Biosciences, 565613), CD64 PE-Cy7 (X54-5/7.1, BioLegend, 139314), Sca-1 allophycocyanin (D7, BioLegend, 108112), CD16/32 allophycocyanin-R700 (2.4G2, BD Biosciences, 565502), CD11c allophycocyanin-780 (N418, eBio-science, 47011482), CD41 BV421 (MWReg30, BD Biosciences, 747729), Ter119 BV510 (TER-119, BD Biosciences, 563995), Ly6G BV605 (1A8, BD Biosciences, 563005), CX3CR1 BV650 (SA011F11, BioLegend, 149033), c-Kit BV711 (2B8, BD Biosciences, 105835), CD45 BV786 (30-F11, BD Biosciences, 564225), CD3e BUV395 (145-2C11, BD Biosciences, 563565), CD11b BUV737 (M1/70, BD Biosciences, 564443), CD68 PerCP-Cy5.5 (FA-11, BioLegend, 137010), VCAM1 Alexa Fluor 647 (429, BioLegend, 105712), MHC class II Alexa Fluor 700 (M5/114, Thermo Fisher Scientific, 56532182), Siglec-F BV421 (E50-2440, BD Biosciences, 562681), Tim-4 BV510 (21H12, BD Biosciences, 742774), Live/Dead, fixable UV (Thermo Fisher Scientific, L34962).
+ Open protocol
+ Expand
5

Quantification and Characterization of Microparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantification of the number of MPs and their phenotypic characterization in the pellet were conducted by flow cytometry (Facscalibur, Becton Dickinson, USA). The MP size gate was set between 200 and 1000 nm using fluorescent latex beds 0.2, 0.5, and 1 µm (Precision Size Standards, Polysciences). The total number of MPs was defined as all the events falling within the MP gate. To count the number of MPs, an aliquot of resuspended MP pellet (100 µL) was added to TruCount (Becton Dickinson, USA) (100 µL), followed by counting up to 2000 0.5 µL bead components of TruCount (total absolute count of MPs = (events in region except beads/events in region of beads) × (absolute number of beads/µL/sample volume (µL)). The origin of MPs was determined by flow cytometry using the cell specific monoclonal antibodies (BD bioscience) and annexin V FITC as follows: erythrocyte-derived microparticles—GlyA PE CD235 (clone GAR-2 (HIR2)), platelet-derived microparticles—CD42bPE-CyTM5 (clone HIP1), leukocyte-derived microparticles—CD45PerCP-CyTM5,5 (clone TU116), endothelial-derived microparticles—CD144 PE (clone 55-7H1).
+ Open protocol
+ Expand
6

Comprehensive Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following Abs were used for flow cytometry: CD115 Alexa Fluor 488 (AFS98, BioLegend, 135512), CD93 PerCP-Cy5.5 (AA4.1, BioLegend, 136512), CD144 PE (11D4.1, BD Biosciences, 562243), F4/80 PE-CF594 (T45-2342, BD Biosciences, 565613), CD64 PE-Cy7 (X54-5/7.1, BioLegend, 139314), Sca-1 allophycocyanin (D7, BioLegend, 108112), CD16/32 allophycocyanin-R700 (2.4G2, BD Biosciences, 565502), CD11c allophycocyanin-780 (N418, eBio-science, 47011482), CD41 BV421 (MWReg30, BD Biosciences, 747729), Ter119 BV510 (TER-119, BD Biosciences, 563995), Ly6G BV605 (1A8, BD Biosciences, 563005), CX3CR1 BV650 (SA011F11, BioLegend, 149033), c-Kit BV711 (2B8, BD Biosciences, 105835), CD45 BV786 (30-F11, BD Biosciences, 564225), CD3e BUV395 (145-2C11, BD Biosciences, 563565), CD11b BUV737 (M1/70, BD Biosciences, 564443), CD68 PerCP-Cy5.5 (FA-11, BioLegend, 137010), VCAM1 Alexa Fluor 647 (429, BioLegend, 105712), MHC class II Alexa Fluor 700 (M5/114, Thermo Fisher Scientific, 56532182), Siglec-F BV421 (E50-2440, BD Biosciences, 562681), Tim-4 BV510 (21H12, BD Biosciences, 742774), Live/Dead, fixable UV (Thermo Fisher Scientific, L34962).
+ Open protocol
+ Expand
7

Characterization of Cell Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were generated by digestion of confluent cells. A total of 106 cells were incubated with antibodies or an isotype control antibody at 4°C for 30 min in the dark. Samples were washed twice with PBS and analyzed with an FACS Calibur flow cytometer (Becton Dickinson). Specific antibodies used in these analyses were CD34-PE, CD29-PE, CD90-PE, CD45-FITC, CD73-FITC, CD105-FITC, CD14-PE, CD19-PE, CD4-PE, CD8-APC (Biolegend, USA), VEGFR-2-PE, CD144-PE (BD, USA), vWF-FITC (Abcam, USA), CD31-FITC (eBioscience, USA), MHC I-PE, MHC II-PE, CD40-PE, CD80-PE, CD86-PE (Miltenyi Biotec) and isotype control IgG-PE (from Miltenyi Biotec or Biolegend, USA), IgG-FITC (from ebioscience or Biolegend, USA), Flow cytometric data were analyzed using BD CELLQuest software.
+ Open protocol
+ Expand
8

Rabbit Carotid Artery Stent Implantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All care and handling of the animals were provided according to the Guide for the care and use of Laboratory Animals approved by the Ethical Committee of Researches of Nanjing University.
In brief, 30 male rabbits (New Zealand white) with a body weight between 3.5 and 4.0 kg were randomly implanted with BMS (n = 15) and VE-cad-Z stents (n = 15) in the left carotid arteries and were followed for 3 and 30 days. Anesthesia was induced with an injection of intramuscular ketamine (30 mg/kg) and intravenous pentobarbital (30 mg/kg) and then maintained using isoflurane and oxygen. Through a longitudinal left neck incision, left common carotid artery exposed. Before arterial clamping, heparin (100 U/kg) was administered intravenously. Then, a BMS or VE-cad-Z stent was implanted in the left common coated 35-mm diameter tissue culture plates (BD Biosciences). Medium was changed daily for 7 days and then every other day till the first passage. To further confirm the OECs phenotype, the cultured cells were incubated with monoclonal antibodies against CD31-PE, CD144-PE, CD34-PE (BD Bioscience), CD14-FITC, CD45-FITC (Immunotech), and CD133-PE (R&D Systems) and analyzed using a fluorescenceactivated cell sorting (FACS) flow cytometer and Win-MDI software (Becton Dickinson).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!